July 23 — 24, 2024 BOSTON, MA

Tabletop Exhibit
Plenary Presentation

Tumor Models Boston Summit 2024

Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to share more information about our platform of 3D patient-derived organoids (PDOs), as well as how leveraging Tempus PDOs can help address common pain points in pre-clinical cancer research and drug development.

Schedule a meeting with us
Plenary Presentation
July 23, 2024
live session
9:00 am–9:30 am ET

The Westin Boston Seaport District
425 Summer Street Boston, MA 02210
Michelle Mack Senior Director, Business Development, Biological Modeling (Tempus)

Lab-in-the-loop: Leveraging Tumor Organoids and RWD to Generate Multimodal Insights for Drug Development

High failure rates and increased costs in drug development are driven by lack of robust preclinical models in the discovery and translational space. Tempus has built a platform of 3D patient-derived organoids (PDOs) grounded in de-identified real-world clinical data to address this gap. With one of the largest, pan-indication patient-derived organoid repositories in the industry, Tempus' portfolio of fixed screening panels supports research questions across a range of modalities including small molecules, antibody drug conjugates, and cell therapies.

Read more

Schedule a meeting with us

We'll be in touch shortly.